Kimberly Sims
Nurse Practitioner · Dothan, ALNPI 1518381854
Payments from drug & device makers
Across 172 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$376
- AbbVie$314
- GSK$290
- Johnson & Johnson$284
- AstraZeneca$262
- Nevro Corp.$197
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,76699%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 35 | $376 |
| AbbVie | 20 | $314 |
| GSK | 17 | $290 |
| Johnson & Johnson | 27 | $284 |
| AstraZeneca | 9 | $262 |
| Nevro Corp. | 9 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $128 |
| Biohaven Pharmaceuticals, Inc. | 4 | $114 |
| Abbott | 8 | $110 |
| Amgen | 6 | $101 |
| Pfizer | 5 | $88 |
| Amarin Pharma, Inc. | 4 | $76 |
| Medtronic | 1 | $59 |
| Alnylam Pharmaceuticals Inc. | 1 | $56 |
| Boehringer Ingelheim | 3 | $50 |
| Astellas Pharma US Inc | 3 | $49 |
| Dexcom, Inc. | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Lilly USA, LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Corcept Therapeutics | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
How this compares
$2,785 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 79 | $56,829 |
| Breo ElliptaFluticasone/Vilanterol | 42 | $22,229 |
| OzempicSemaglutide | 22 | $21,373 |
| JardianceEmpagliflozin | 21 | $21,039 |
| JanuviaSitagliptin Phosphate | 25 | $19,486 |
| TrulicityDulaglutide | 12 | $11,703 |
| EliquisApixaban | 18 | $11,517 |
| Fluticasone Propionate | 251 | $3,599 |
| Tizanidine Hcl | 184 | $1,913 |
| Celecoxib | 104 | $1,439 |
| Atorvastatin Calcium | 155 | $1,357 |
| Levothyroxine Sodium | 99 | $1,272 |
| Omeprazole | 98 | $1,248 |
| Duloxetine Hcl | 56 | $1,228 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $262 | $56,82979 claims |
| GSKBreo Ellipta | $290 | $22,22942 claims |
| Novo NordiskOzempic | $376 | $21,37322 claims |
| Boehringer IngelheimJardiance | $50 | $21,03921 claims |
| Lilly USA, LLCTrulicity | $29 | $11,70312 claims |
| PfizerEliquis | $88 | $11,51718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Dothan
- Hollie CrutchfieldDothan$22K
- Christina BellDothan$14K
- Shea CalhounDothan$14K
- Amanda PybusDothan$13K
- Tami CaldwellDothan$13K
- Alison HallDothan$12K
- Jennifer ParrishDothan$12K
- Amanda SewellDothan$11K
- Amy EthridgeDothan$11K
- Allison McAllisterDothan$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.